Bioregenx, Inc.
FDIT
Revenue
596.04k
▼-138.00k▼-18.80%
3 Months ChangeAssets
17.36M
▼-529.50k▼-2.96%
3 Months ChangeLiabilities
3.80M
▲130.96k▲3.57%
3 Months ChangeFree Cash Flow
-293.64k
▲43.15k▲12.81%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-06-11
Form 8-K
ID: 0001683168-24-004095
2024-05-24
Form 10-Q
ID: 0001683168-24-003807
2024-05-16
Form 8-K
ID: 0001683168-24-003582
2024-04-01
Form 8-K
ID: 0001683168-24-001917
2023-11-20
Form 10-Q
ID: 0001683168-23-008360
2023-08-15
Form 10-Q
ID: 0001683168-23-005813
2023-05-22
Form 10-Q
ID: 0001683168-23-003620
2023-01-06
Form 8-K
ID: 0001800943-23-000001
2022-11-21
Form 10-Q
ID: 0001800943-22-000015
2022-08-12
Form 10-Q
ID: 0001800943-22-000013